Business Description
Entropy Neurodynamics Limited is an Australian pharmaceutical company working to develop new treatments for conditions that current medicines have struggled to address, including binge eating disorder, fibromyalgia, and irritable bowel syndrome. Its two main drug candidates combine psilocin ? a naturally occurring psychedelic compound ? with psychotherapy, and are being tested in clinical trials across Australia, Canada, Switzerland, and the United States. Founded in 2019 and headquartered in Camberwell, Australia, the company was previously called Tryptamine Therapeutics Limited before rebranding in November 2025.
